Clinical Trial Update: Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy [Phase 2]

View source ↗

Summary

Phase 2 study of atezolizumab after chemo-radiotherapy for muscle-invasive bladder cancer patients who are not eligible for radical cystectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: UNICANCER | Conditions: Bladder Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING